Businesses and government agencies are pushing employees to get vaccinated amid a surge in new coronavirus infections across the country.
Tag: National Institutes of Health
U.S. Had More Covid-19 Cases Than Reported, N.I.H. Study Says
Researchers estimated that there were nearly 20 million infected adults at a time when the number was reported to be closer to three million.
Scientists Report Earliest Known Coronavirus Cases in Five US States
Blood drawn from nine people in the earliest days of the pandemic tested positive for the infection. But some experts questioned the results.
The C.D.C. and N.I.H. launch a rapid, at-home testing initiative in Tennessee and North Carolina.
The new initiative is an important step in determining whether widespread rapid testing can help curb transmission of the virus.
Rich Countries Signed Away a Chance to Vaccinate the World
Despite warnings, American and European officials gave up leverage that could have guaranteed access for billions of people. That risks prolonging the pandemic.
Future Vaccines Depend on Test Subjects in Short Supply: Monkeys
The pandemic has highlighted the United States’ dependence on China for research animals, reviving calls for a “strategic monkey reserve.”
Governments Sign Secret Vaccine Deals. Here’s What They Hide.
Multibillion-dollar contracts give drug makers liability shields, patent ownership and leeway on delivery dates and pricing — and promises that much of it will not be made public.
Trial of High-Dose Blood Thinners in I.C.U. Coronavirus Patients Is Halted
Giving anticoagulants to hospitalized Covid-19 patients is routine. But high doses may sometimes do more harm than good, a safety board finds.
Moderna Vaccine Is Highly Protective and Prevents Severe Covid, Data Show
The positive review most likely ensures that the Food and Drug Administration will grant emergency authorization to a second coronavirus vaccine this week for millions of Americans.
How the US, UK and Canada Will Roll Out the Covid Vaccine
Within days, all three countries could be giving the Pfizer-BioNTech vaccine, but they have varying strategies and challenges. The U.S. plan, working through the states, is the least centralized.